Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pros and cons of inhibiting cholesteryl ester transfer protein.

Current opinion in lipidology - 1 Dec 2000

Hirano K, Yamashita S, Matsuzawa Y

Abstract excerpt

Whether or not it is desirable to inhibit cholesteryl ester transfer protein (CETP) has been an important question for over fifteen years since genetic CETP deficiency was found. Recently, some epidemiological studies which have been reported in Japan as well as Western countries help to clarify the atherogenicity of human subjects with mutations or polymorphisms in the CETP gene. In addition, some experimental...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteriosclerosis
Share to Biological Transport
Share to Carrier Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholesterol Ester Transfer Proteins

Share to Cholesterol, HDL

Share to Cholesterol, LDL

Share to Glycoproteins

Share to Rabbits

Source

Identifiers

PMID: 11086331
DOI: 10.1097/00041433-200012000-00004

Genes

CETP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pros and cons of inhibiting cholesteryl ester transfer protein.PMID 11086331Read ↗

Cholesteryl Ester Transfer Protein (CETP) Variations in Relation to Lipid Profiles and Cardiovascular Diseases: An Update.Semantic proximity Read ↗

CETP inhibitors and cardiovascular disease: Time to think againSemantic proximity Read ↗

Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.Semantic proximity Read ↗

Cholesteryl ester transfer protein: an enigmatic protein.Semantic proximity Read ↗

Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease.Semantic proximity Read ↗

[Advances on the research of the relationship between cholesteryl ester transfer protein and atherosclerosis].Semantic proximity Read ↗

Cholesteryl ester transfer protein: the controversial relation to atherosclerosis and emerging new biological roles.Semantic proximity Read ↗

Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.Semantic proximity Read ↗

Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.Semantic proximity Read ↗

Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?Semantic proximity Read ↗

A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load.Semantic proximity Read ↗

An overview of reverse cholesterol transport.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.